Amedisys (AMED) PT Lowered to $139 at RBC Capital
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
RBC Capital analyst Frank Morgan lowered the price target on Amedisys (NASDAQ: AMED) to $139.00 (from $165.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
- Global-E Online Ltd (GLBE) PT Raised to $47 at Truist Securities
- ASICS Corporation (7936:JP) (ASCCY) PT Raised to JPY6,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
